Literature DB >> 15689957

Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat.

Marguerite T Littleton-Kearney1, Judy A Klaus, Patricia D Hurn.   

Abstract

The reason that estrogen is strongly protective in various estrogen-deficient animal models while seemingly detrimental in postmenopausal women remains unclear. It hypothesized that prolonged oral medroxyprogesterone (MPA) plus oral conjugated equine estrogens (CEE) diminishes estrogen ability to reduce stroke damage in the rodent stroke model. To test the hypothesis, we fed ovariectomized rats CEE or MPA, or a combination of CEE and MPA (CEP), before inducing 120 min of reversible focal stroke, using the intraluminal filament model. After 22 h reperfusion, the brains were harvested and infarction volumes were quantified. Treatment with CEE alone or with CEP reduced cortical infarction volume. However, CEP failed to provide ischemic protection in subcortical regions. It was concluded that CEE alone, or with CEP, is neuroprotective in the cortex, but interactive effects between the hormones may counteract CEE beneficial effects in subcortical brain regions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689957     DOI: 10.1038/sj.jcbfm.9600052

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  18 in total

Review 1.  Progesterone exerts neuroprotective effects after brain injury.

Authors:  Donald G Stein
Journal:  Brain Res Rev       Date:  2007-07-27

2.  Conjugated equine estrogen enhances rats' cognitive, anxiety, and social behavior.

Authors:  Alicia A Walf; Cheryl A Frye
Journal:  Neuroreport       Date:  2008-05-07       Impact factor: 1.837

3.  Conjugated equine estrogen, with medroxyprogesterone acetate, enhances formation of 5alpha-reduced progestogens and reduces anxiety-like behavior of middle-aged rats.

Authors:  Cheryl A Frye; Alicia A Walf; Jason J Paris
Journal:  Behav Pharmacol       Date:  2010-09       Impact factor: 2.293

Review 4.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

Review 5.  Sex differences in stroke.

Authors:  Roy A M Haast; Deborah R Gustafson; Amanda J Kiliaan
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-03       Impact factor: 6.200

Review 6.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 7.  Estrogens and progesterone as neuroprotectants: what animal models teach us.

Authors:  Meharvan Singh; Nathalie Sumien; Cheryl Kyser; James W Simpkins
Journal:  Front Biosci       Date:  2008-01-01

8.  Buyang Huanwu Decoction () reduces infarct volume and enhances estradiol and estradiol receptor concentration in ovariectomized rats after middle cerebral artery occlusion.

Authors:  Bai-yan Liu; Xiao-ling Song; Jian Yi; Xue-mei Chen; Yue Yu; Hui Liu; Guang-xian Cai
Journal:  Chin J Integr Med       Date:  2014-08-07       Impact factor: 1.978

Review 9.  Progesterone-induced neuroprotection: factors that may predict therapeutic efficacy.

Authors:  Meharvan Singh; Chang Su
Journal:  Brain Res       Date:  2013-01-20       Impact factor: 3.252

Review 10.  Sex, sex steroids, and brain injury.

Authors:  Paco S Herson; Ines P Koerner; Patricia D Hurn
Journal:  Semin Reprod Med       Date:  2009-04-28       Impact factor: 1.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.